T-cell Therapy Market- Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020-2030

  • Single User License $3500

T-cell Therapy Market- Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020-2030

Status : January, 2022 | Biotechnology

Report Digest


T-cell Therapy Market: Overview

The T-cell therapy market is anticipated to rise at a stellar growth rate for the forecast period between 2020 and 2030. The shift in medical practices from small molecule and protein-based therapies to adoptive therapies that has attracted strategic investments by both public and private agencies is creating opportunities in the T-cell therapy.

Key parameters based on which the T-cell therapy market is divided in this report are modality, therapy type, indication, and region.

The report provides an in-depth analysis of demand drivers, trends, and opportunities in the T-cell therapy market for the 2020 – 2030 forecast period. Furthermore, the report throws lights on key segments along with their growth rate estimations for the aforementioned forecast period. Last but not the least, the report discusses the competitive landscape of the T-cell therapy market. This includes insights into growth strategies of key players along with their revenue share estimation in the T-cell therapy market for the 2020 – 2030 forecast period.

T-cell Therapy Market: Competitive Landscape

The T-cell therapy market is fiercely competitive due to the presence of some large players in the fray. With increasing approvals of T-cell therapy and expanding manufacturing capabilities, competition in the market is expected to intensify in the future. For example, in December 2020, the European Medicine Agency issued market authorization for Tecartus – the only CAR-T therapeutic product from Kite Pharma for mantle cell lymphoma.

Key players operating in the T-cell therapy market include;

  • Novartis AG
  • Bluebird Bio, Inc.
  • Gilead Science
  • Sorrento Therapeutics
  • TCR2 Therapeutics Inc.
  • Fate Therapeutics
  • Merck KgaA
  • Amgen
  • Pfizer Inc.
  • Celgene Corporation.

T-cell Therapy Market: Key Trends

First and foremost, substantial application of T-cell mechanism in cancer immunotherapy due to its high success rate fuels growth in the T-cell therapy market. As of June 2020, above 350 CAR-T clinical trials registered in China. This data indicates the increasing significance of Chimeric Antigen Receptor therapy for the treatment of cancer.

Besides this, expanding role of gene therapy for the treatment of a number of rare diseases is spawning demand for CAR-T therapies. With increasing adoption of gene therapy, the T-cell therapy market is expected to touch new frontiers over the forecast period from 2020 to 2030.

Over the COVID-19 pandemic, increasing investments to decipher the application of T-cell therapies for viral infection research is adding a new dimension to the growth of T-cell therapy market. In this context, a study published in December 2020 demonstrates the potential of T-cell therapy to treat high-risk COVID-19 patients.

In another similar case study, in September 2020, the U.S. FDA sanctioned the IND application for the use of ALVR109 to treat COVID-19 patients. This is likely to expand the adoption of T-cell therapies for viral infections.

T-cell Therapy Market: Regional Assessment

North America is the leader among other key regions in the T-cell therapy market. Factors such as a robust research infrastructure for clinical trials of T-cell therapies and a commercial base for T-cell therapies makes the region leader in the overall T-cell therapy market.

The U.S. and Canada predominantly steer growth in the T-cell therapy market in the region. The increasing number of regulatory approvals along with changing reimbursement scenario in the U.S. and Canada have accelerated the uptake of T-cell therapies in these countries. This bolsters the T-cell therapy market in the region.

China has emerged as a key region in the CAR-T therapies market in recent years. The high number of clinical trials undertaken pertaining to these therapies is creating opportunities in the T-cell therapy market in China.

The reports at TMR Research provide qualitative solutions that break the barriers of doubt or uncertainties when the stakeholders plan to expand their growth reach. The researchers compile the necessary information that enlightens the CXOs about the current growth opportunities in a specific market and enables them to make the most of the opportunities.

TMR Research is a leader in developing well-researched reports. The expertise of the researchers at TMR Research makes the report stand out from others. TMR Research reports help the stakeholders and CXOs make impactful decisions through a unique blend of innovation and analytical thinking. The use of innovation and analytical thinking while structuring a report assures complete and ideal information of the current status of the market to the stakeholders.

TMR Research has rich experience in developing state-of-the-art reports for a wide array of markets and sectors. The brilliance of the experts at TMR Research and their alacrity to conduct thorough research and create phenomenal reports makes TMR Research better than others.

5-Point Growth Formula

The 5-point growth formula developed by TMR Research provides an insight to the stakeholders and CXOs about the current situation in the market. The growth formula makes the report a perfect companion for the stakeholders and CXOs.

The 5-point growth formula includes the following points:

  • Current and Future Threats
  • Accurate Trend Analysis
  • Regional Assessment
  • Industrial Analogy
  • COVID-19 Impact

Current and Future Threats

Along with studying the opportunities necessary for growth, threats are also an important aspect to look upon for the companies and stakeholders in a specific sector. TMR Research studies every negative aspect that will hinder the growth of a specific area of business and includes it in the report. The stakeholders and CXOs will have the benefit of assessing the threat and take the necessary steps to prevent the hindrance caused due to the threats.

Accurate Trend Analysis

Keeping up with the latest trends is crucial in any business or sector. While stakeholders are aware of the trends that are on the surface, TMR Researchers find trends that are deeply entrenched in the particular market or sector. The reports are constantly updated with the latest trends so that the stakeholders and CXOs can derive benefits from the trends and generate good revenues.

Regional Assessment

Demography forms an important part of the growth pattern of all the markets. Diving deep into the demographics enables maximum output from specific areas. The TMR Research team assesses every region and picks out the vital points that have a large impact on the growth of a market.

Industrial Analogy

The analysts at TMR Research conduct an all-round analysis on the competitive landscape of the market. The observations recorded by the analysts are added to the reports so that every stakeholder gets a glimpse of the competitive scenario and frame their business plans according to the situation.

COVID-19 Impact

The COVID-19 outbreak has changed the growth projections of numerous sectors and businesses. The analysts at TMR Research have conducted a conscientious survey on the markets after the pandemic struck. The analysts have put forth their brilliant and well-researched opinions in the report. The opinions will help the stakeholders to plan their strategy accordingly.

The reports offer answers to the top 7 questions that revolve around the growth of the market

  • What are the diverse growth parameters influencing the market?
  • Which regions will contribute largely to the growth of the market
  • What are the recent innovations and technological advancements in the market?
  • What are the emerging trends across the market?
  • How has COVID-19 affected the market?
  • What will be the post-pandemic scenario of the market?
  • What are the major threats that will dent the growth prospects of the market?